Ren L, Deng Y, Wang HJ, Ren B, Niu XY, Fan HN. Association of the HLA-DRB1 gene with clinical outcome of Tibetan patients with hepatitis B in Qinghai.
Shijie Huaren Xiaohua Zazhi 2011;
19:1899-1903. [DOI:
10.11569/wcjd.v19.i18.1899]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To assess the association between the leukocyte antigen (HLA)-DRB1 gene and clinical outcome of Tibetan patients with hepatitis B in Qinghai.
METHODS: Polymerase chain reaction-sequence specific primer (PCR-SSP) method was used to determine the frequencies of HLA-DRB1*3/7/12/13/15 alleles in 30 patients with hepatitis B virus (HBV)-associated cirrhosis, 55 patients with hepatitis B and 15 healthy controls from Qinghai Province, China.
RESULTS: The frequency of HLA-DRB1*12 differed significantly among the three groups of subjects (P < 0.05), while the frequencies of the other alleles showed no significant differences among the three groups (all P > 0.05). The frequency of HLA-DRB1*12 allele was significantly higher in patients with HBV-associated cirrhosis B and those with hepatitis B than in healthy controls (GF = 90%, 98.2%; RR = 13.5, 14; both P < 0.05), but showed no significant difference between patients with HBV-associated cirrhosis B and those with hepatitis B (P > 0.05).
CONCLUSION: The HLA-DRB1*12 allele may be associated with susceptibility to hepatitis B in the Tibetan population in Qinghai and may correlate with the development of cirrhosis in patients with HBV infection.
Collapse